Micro Developing Active

Eli Lilly memperluas akses Zepbound untuk pertumbuhan jangka panjang

Skor
0,5
Kecepatan
▲ 0,0
Artikel
9
Sumber
4

Ringkasan

Artikel ini termasuk dalam narasi ini jika membahas perluasan akses Zepbound oleh Eli Lilly dan prospek pertumbuhannya dalam jangka panjang.

Artikel Terkait

Jim Cramer Likes Eli Lilly’s (LLY) New Deal

Yahoo Finance · Apr 05, 2026
Mixed

Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight

Nasdaq · Apr 04, 2026
Mixed

Eli Lilly secures long-awaited FDA approval for its obesity pill. Here's what to know

CNBC · Apr 01, 2026
Mixed

The cutthroat battle for the US weight-loss drug market

BBC Business · Mar 23, 2026
Mixed

Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook

Yahoo Finance · Mar 22, 2026
Mixed

Sumber

Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of … Nasdaq
Jim Cramer Likes Eli Lilly’s (LLY) New Deal Yahoo Finance
Is Eli Lilly and Company (LLY) The Best Pharma Stock … Yahoo Finance
Eli Lilly secures long-awaited FDA approval for its obesity pill. … CNBC
Eli Lilly reaches $2.75 billion deal with Insilico to bring … CNBC
Here's How Much Upside Eli Lilly Stock Has, According to … Yahoo Finance
The cutthroat battle for the US weight-loss drug market BBC Business
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing … Yahoo Finance

Lini Waktu

Terakhir Diperbarui Mar 22, 2026